Supernormal lung function and risk of COPD: A contemporary population-based cohort study

Area of Science:

• Pulmonology
• Epidemiology
• Public Health

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health concern.
• Previous research suggests higher-than-normal lung function may be protective against COPD.
• The specific role of supernormal lung function in COPD development requires further investigation.

Purpose of the Study:

• To test the hypothesis that individuals with supernormal lung function have a reduced risk of developing COPD.
• To investigate the association between supernormal lung function and COPD incidence.
• To explore the impact of supernormal lung function on COPD-related outcomes.

Main Methods:

• A large cohort of 108,246 adults from the Copenhagen General Population Study was followed for clinical COPD outcomes.
• Lung function was assessed, with supernormal lung function defined as forced expiratory volume in 1 second (FEV1) > upper limit of normal (ULN).
• COPD development was determined by FEV1/forced vital capacity (FVC)<0.70 and FEV1<80% predicted with chronic respiratory symptoms.

Main Results:

• 4% of participants exhibited supernormal lung function at baseline.
• No individuals with supernormal lung function developed COPD over a 10-year follow-up period, compared to 3% with normal lung function.
• Supernormal lung function was associated with significantly lower hazard ratios for acute obstructive lung disease hospitalizations (0.19), pneumonia hospitalizations (0.56), and all-cause mortality (0.81).

Conclusions:

• Supernormal lung function is strongly associated with a substantially lower risk of developing COPD.
• Individuals with supernormal lung function experience reduced respiratory and all-cause morbidity and mortality.
• Maintaining optimal lung function may be a key factor in preventing COPD and improving long-term health outcomes.